Skip to main content
Fig. 6 | Biomaterials Research

Fig. 6

From: An injectable, in situ forming and NIR-responsive hydrogel persistently reshaping tumor microenvironment for efficient melanoma therapy

Fig. 6

Immune activation ability of MD@SA hydrogel. (a) The polarization of macrophages by the supernatant of B16F10 cells after various treatments. (b-d) The gene expressions of cytokines IL-1β, IL-6, and TNF-α in M1 macrophages. (e) Cell viability of B16F10 cells after supplemented with the supernatant from M1 macrophages. (f) The re-education of M2 macrophages into M1 phenotype by the supernatant from B16F10 cells treated with MD@SA and MD@SA + NIR, respectively

Back to article page